




Entertainment
View All
Philadelphia Guitarist Greg Sover Releases New Single and Video
PHILADELPHIA, PA — After leaving an indelible mark on the rock and blues scene nearly three years ago with his critically acclaimed album His-Story, Philadelphia guitar virtuoso Greg Sover is …
Lifestyle
View All
Malvern Wreath Ceremony Honors 52 Fallen Revolutionary Soldiers
MALVERN, PA — Fifty-two Continental soldiers who lost their lives in the Battle of Paoli will be remembered with Christmas wreaths when the Paoli Battlefield hosts its annual Wreaths Across …
Pennsylvania
View All
New York Man Accused of Supplying Cocaine to Penn State Fraternities
WILLIAMSPORT, PA — A 24-year-old New York man faces federal drug trafficking charges after allegedly supplying large quantities of cocaine to two Penn State University fraternities between January 2023 and …
National
View All
Fetterman Pushes USDA to Halt SNAP Eligibility Restrictions
WASHINGTON, D.C. — U.S. Sen. John Fetterman, D-Pa., joined 10 Senate Democrats in urging the Department of Agriculture to withdraw proposed food assistance restrictions that could eliminate Supplemental Nutrition Assistance …
Latest Articles
View AllBTCS Profit Hits $54.5M as DeFi Revenue More Than Doubles
WAYNE, PA — BTCS Inc. (Nasdaq: BTCS) reported a $54.5 million third-quarter profit, reversing a $34.9 million loss in the previous quarter, as rising Ethereum prices boosted the value of …
Annovis Secures Buntanetap Patent Ahead of Alzheimer’s Trial Data
MALVERN, PA — Annovis Bio Inc. (NYSE: ANVS) has secured U.S. patent protection through June 2044 for the formulation of its experimental Alzheimer’s and Parkinson’s treatment buntanetap, strengthening its intellectual …
Century Therapeutics Cuts Loss as Cell Therapies Near Trials
PHILADELPHIA, PA — Century Therapeutics Inc. (Nasdaq: IPSC) narrowed its third-quarter net loss by 32% to $23.5 million as it reduced research spending and prepared two experimental cell therapies for …
Traws Pharma Targets FDA Path for COVID Antiviral
NEWTOWN, PA — Traws Pharma Inc. (Nasdaq: TRAW) plans to pursue a regulatory pathway for its experimental COVID-19 treatment in patients unable to take Pfizer’s Paxlovid after a 92-patient Phase …
Ashland Sets December 15 Dividend Payment at 42 Cents
WILMINGTON, DE — Ashland Inc. (NYSE: ASH) will pay a quarterly cash dividend of 42 cents per common share on December 15, 2026, returning approximately $19.3 million to shareholders based …
